Roxadustat and thyroid-stimulating hormone suppression

被引:28
|
作者
Tokuyama, Atsuyuki [1 ]
Kadoya, Hiroyuki [1 ]
Obata, Atsushi [2 ,3 ]
Obata, Takahiro [3 ]
Sasaki, Tamaki [1 ]
Kashihara, Naoki [1 ]
机构
[1] Kawasaki Med Sch, Dept Nephrol & Hypertens, Okayama, Japan
[2] Kawasaki Med Sch, Dept Diabet Endocrinol & Metab, Okayama, Japan
[3] Obata Med Clin, Okayama, Japan
关键词
end-stage renal disease; hemodialysis; hypothyroidism; hypoxia-inducible factor prolyl-hydroxylase inhibitor; levothyroxine sodium hydrate; roxadustat; ANEMIA;
D O I
10.1093/ckj/sfab007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Hypoxia-inducible factor prolyl-hydroxylase inhibitors belong to a new class of orally administered drugs for treating anemia in patients with chronic kidney disease (CKD). The prevalence of hypothyroidism is disproportionately high in patients with CKD on hemodialysis. We report a rapid suppression of thyroid-stimulating hormone (TSH) and decrease in free triiodothyronine (T3) and free tetraiodothyronine levels after switching from darbepoetin alfa to roxadustat in a hemodialysis patient with hypothyroidism on levothyroxine therapy. This was reversed after stopping roxadustat. Roxadustat has structural similarity with T3 and is a selective activating ligand for thyroid hormone receptor-beta possibly suppressing TSH release.
引用
收藏
页码:1472 / 1474
页数:3
相关论文
共 50 条
  • [1] THYROID-STIMULATING HORMONE RECEPTOR AND THYROID-STIMULATING ANTIBODIES
    SMITH, BR
    HALL, R
    [J]. JOURNAL OF ENDOCRINOLOGY, 1974, 63 (02) : P59 - P60
  • [2] THYROID-STIMULATING HORMONE
    PURVES, HD
    ADAMS, DD
    [J]. BRITISH MEDICAL BULLETIN, 1960, 16 (02) : 128 - 132
  • [3] The Thyroid-Stimulating Hormone Receptor: Impact of Thyroid-Stimulating Hormone and Thyroid-Stimulating Hormone Receptor Antibodies on Multimerization, Cleavage, and Signaling
    Latif, Rauf
    Morshed, Syed A.
    Zaidi, Mone
    Davies, Terry F.
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2009, 38 (02) : 319 - +
  • [4] The Influence of Thyroid-Stimulating Hormone and Thyroid-Stimulating Hormone Receptor Antibodies on Osteoclastogenesis
    Ma, Risheng
    Morshed, Syed
    Latif, Rauf
    Zaidi, Mone
    Davies, Terry F.
    [J]. THYROID, 2011, 21 (08) : 897 - 906
  • [5] An immunoglobulin G complexed form of thyroid-stimulating hormone (macro thyroid-stimulating hormone) is a cause of elevated serum thyroid-stimulating hormone concentration
    Mills, Francesca
    Jeffery, Jinny
    Mackenzie, Paul
    Cranfield, Alex
    Ayling, Ruth M.
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2013, 50 (05) : 416 - 420
  • [6] SUPPRESSION OF MATERNAL PITUITARY THYROID-STIMULATING HORMONE DURING PREGNANCY
    BROTHERTON, J
    [J]. HUMAN REPRODUCTION, 1990, 5 (04) : 471 - 475
  • [7] Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships
    Szkudlinski, MW
    Fremont, V
    Ronin, C
    Weintraub, BD
    [J]. PHYSIOLOGICAL REVIEWS, 2002, 82 (02) : 473 - 502
  • [8] THYROID-STIMULATING HORMONE IN THYROID DYSGENESIS
    KULIN, HE
    KOHLER, PO
    OMALLEY, BW
    ODELL, WD
    [J]. JOURNAL OF PEDIATRICS, 1967, 71 (05): : 714 - +
  • [10] THYROID-STIMULATING HORMONE AND DEPRESSION
    STEWART, JW
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1982, 139 (12): : 1646 - 1646